Relationship between Serum Levels of Oxidative Stress Markers and Metabolic Syndrome Components in PCOS Women

Jump To References Section


  • Department of Studies in Zoology, University of Mysore, Manasagangotri, Mysuru – 570005, Karnataka ,IN
  • Department of Studies in Genetics and Genomics, University of Mysore, Manasagangothri, Mysuru, Karnataka ,IN



Antioxidants, Metabolic Syndrome, Oxidative Stress, PCOS


Background: Polycystic Ovarian Syndrome (PCOS) is a common endocrinological problem that leads to infertility in reproductive age. It is strongly associated with oxidative stress, which increases the risk of Metabolic Syndrome (Met-S) in women. This study aimed to evaluate the relationship between oxidative stress markers and metabolic syndrome parameters in PCOS women. Methods: In this cross-sectional study, we included age-matched 100 control and 150 PCOS (according to Rotterdam criteria). Anthropometric measurements were obtained from each subject. Lipid profile, Fasting Plasma Glucose (FPG), and insulin were determined. Serum Malondialdehyde (MDA), Nitric Oxide (NO), and Reactive Oxygen Species (ROS) levels are pro-oxidant indicators, while for antioxidant activities, Superoxide Dismutase (SOD), Catalase (CAT), Glutathione (GSH), Vitamin-C (Vit C), and Total Antioxidant Capacity (TAC) activity were measured by spectrophotometry. Results: In the PCOS group the SOD, CAT, GSH, Vit C, and TAC activity were significantly low, whereas NO, ROS, and MDA were significantly high (p < 0.05). In the PCOS group, the pro-oxidant MDA showed a negative correlation with HDL and a positive correlation with DBP. The antioxidants SOD and CAT showed a negative correlation with fasting blood glucose and triglycerides. Conclusion: The metabolic syndrome components of PCOS can induce oxidative stress, which is evidenced by a decrease in antioxidant defence mechanisms. It is probably because oxidative stress itself is the consequence of PCOS, more so with Met-S which increases the pro-oxidant state and decreases the anti-oxidant capacity in women.


Download data is not yet available.


Metrics Loading ...




How to Cite

Lakshmi, K., & Malini, S. S. (2023). Relationship between Serum Levels of Oxidative Stress Markers and Metabolic Syndrome Components in PCOS Women. Journal of Endocrinology and Reproduction, 27(1), 29–39.



Original Research



Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016; 106:6-15. fertnstert.2016.05.003 PMid:27233760 DOI:

Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007; 370(9588):685-97. PMid: 17720020 DOI:

Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: A comprehensive investigation. Fertil Steril. 2010; 93:2421-3. PMid:20117778 DOI:

Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2010; 16:347-63. PMid:20159883 DOI:

Chen L, Xu WM, Zhang D. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with Polycystic Ovary Syndrome. Fertil Steril. 2014; 102(4):1167-74. fertnstert.2014.06.027 PMid:25064406 DOI:

Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735-52. CIRCULATIONAHA. 105.169404 PMid:16157765 DOI:

Caserta D, Adducchio G, Picchia S, et al. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol. 2014; 30:397-402. PMid: 24552422 DOI:

Lim SS, Kakoly NS, Tan JWJ, et al. Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression. Obes Rev. 2019; 20(2):339-52. PMid:30339316 DOI:

Otaghi M, Azami M, Khorshidi A, et al. The association between metabolic syndrome and polycystic ovary syndrome: A systematic review and meta-analysis. Diab Metab Syndr. 2019; 13(2):1481-9. https://doi. org/10.1016/j.dsx.2019.01.002 PMid:31336510 DOI:

Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012; 10:49. https://doi. org/10.1186/1477-7827-10-49 PMid:22748101 PMCid: PMC3527168 DOI:

Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and Polycystic Ovary Syndrome (PCOS): A systematic review and meta-analysis. Hum Reprod Update. 2013; 19(3):268-88. https:// PMid:23303572 DOI:

Desai V, Prasad NR, Manohar SM, et al. Oxidative stress in non-obese women with polycystic ovarian syndrome. J Clin Diagn Res. 2014; 8:CC01-03.

Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006; 91:336-40. PMid:16249279 DOI:

Papalou O, Victor VM, Diamanti-Kandarakis E. Oxidative stress in polycystic ovary syndrome. Curr Pharm Des. 2016; 22:2709-22. 381612822666160216151852 PMid:26881435 DOI:

Victor VM, Rocha M, Bañuls C, et al. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2009; 94:3505-12. https://doi. org/10.1210/jc.2009-0466 PMid:19567514 DOI:

The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81:19- 25. DOI:

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502. clinchem/18.6.499 PMid:4337382 DOI:

Cleeman JI, Grundy SM, Becker D, et al. Cholesterol Educ program, executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285:2486-97. jama.285.19.2486 PMid:11368702 DOI:

Bernheim F, Bernheim MLC, Wilbur KM. The reaction between thiobarbituric acid and the oxidation products of certain lipids. J Biol Chem. 1948; 174(1):257-64. PMid: 18914082 DOI:

Black MJ, Brandt RB. Spectrofluorometric analysis of hydrogen peroxide. Anal Biochem. 1974; 58(1):246-54 PMid: 4825377 DOI:

Grisham MB, Johnson GG, Lancaster JR. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol. 1996; 268:237-46, S0076-6879(96)68026-4 PMid:8782590 DOI:

Kazari D. A modified spectrophotometric assay of superoxide dismutase using nitrate formation by superoxide radical. Ind J Biochem Biophys. 2000; 57:201-4.

Aebi H. Catalase in vitro methods. Enzymology 1984; 105:121-6. PMid: 6727660 DOI:

Moron M, Depierre J, Mannervik B. Levels of glutathione, glutathione reductase and glutathione s-transferase activities in rat lung and liver. Biochim Biophys Acta (BBA)- General Subjects. 1979; 582(1):67-78 https://doi. org/10.1016/0304-4165(79)90289-7 DOI:

Subash-Babu P, Alshatwi AA, Ignacimuthu S. Beneficial antioxidative and antiperoxidative effect of cinnamaldehyde protect streptozotocin induced pancreatic β-cells damage in Wistar rats. Biomol Therapeut. (Seoul). 2014; 22(1):47-54. PMid: 24596621 PMCid:PMC3936432 DOI:

Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: Specific application to the determination of vitamin E. Anal Biochem. 1999; 269(2):337-41. PMid:10222007 DOI:

Rocha MP, Marcondes JAM, Barcellos CRG, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol. 2011; 27:814-19. 508852 PMid:20807166 DOI:

Ruan X, Li M, Mueck AO. Why does Polycystic Ovary Syndrome (PCOS) need long-term management? Curr Pharm Des. 2018; 24:4685-92. PMid:30706800 DOI:

Mujica LS, Bridi A, Méa RD, et al. Oxidative stress and metabolic markers in pre- and postnatal polycystic ovary syndrome rat protocols. J Infamm Res. 2018; 11:193-202. PMid:29805266 PMCid:PMC5960249 DOI:

Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta. 2001; 306(1-2):1-17. PMid: 11282089 DOI:

Wang H, Ruan X, Li Y, et al. Oxidative stress indicators in Chinese women with PCOS and correlation with features of metabolic syndrome and dependency on lipid patterns. Arch Gynecol Obstet. 2019; 300(5):1413-21. 05305-7 PMid: 31549221 DOI:

Zhang D, Luo WY, Liao H, et al. The effects of oxidative stress to PCOS. J Sichuan Univ Med Sci Ed. 2008; 39:421-3.

Kuşçu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2009; 88:612-7. https://doi. org/10.1080/00016340902859315 PMid:19308750 DOI:

Oyebanji O, Asaolu, M. Assessment of antioxidant status of women with polycystic ovarian syndrome. Asian Pac J Reprod. 2020; 9(1):9. 0500.275523 DOI:

Taylor BS, Kim YM, Wang Q, et al. Nitric oxide downregulates hepatocyte-inducible nitric oxide synthase gene expression. Arch Surg. 1997; 132:1177-83. https:// PMid:9366709 DOI:

Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Investig. 1996; 98:894-8. PMid: 8770859 PMCid:PMC507502 DOI:

Nacul AP, Andrade CD, Schwarz P, et al. Nitric oxide and fibrinogen in polycystic ovary syndrome: Associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol. 2007; 133:191-6. ejogrb.2006.09.009 PMid:17049715 DOI:

Baskol G, Aygen E, Erdem F, et al. Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2012; 91:326-30. 0412.2011.01337.x PMid:22168506 DOI:

Fatima Q, Amin S, Kawa IA, et al. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study. Diabetes Metab Syndr. 2019; 13(3);1957-61. dsx.2019.04.032 PMid:31235121 DOI:

Al-Azzawie HF, Humadi EH. Oxidative stress and antioxidant mechanisms in a sample of Iraqi patients with polycystic ovary syndrome. Iraqi J Comm Med. 2010; 3:196-200.

Kandasamy S, Sivagamasundari RI, Bupathy A, et al. Evaluation of insulin resistance and oxidative stress in obese patients with polycystic ovary syndrome. Int Jappl Biol Pharm. 2010; 2:391-98.

Seleem AK, El Refaeey AA, Shaalan D, et al. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet. 2014; 31:499-504. 014-0190-7 PMid:24526356 PMCid: PMC3969459 DOI:

Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999; 27:916-21. https://doi. org/10.1016/S0891-5849(99)00177-X PMid:10569624 DOI:

Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001; 34(5):407-13. 9120(01)00245-4 PMid:11522279 DOI:

Dincer Y, Akcay T, Erdem T, et al. DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Invest. 2005; 65(8):721-28. https://doi. org/10.1080/00365510500375263 PMid:16509054 DOI:

Surapaneni KM, Vishnu PV. Lipid peroxidation, glutathion, ascorbic acid, vit E, antioxidant enzyme and serum homocysteine status in patients with polycystic ovary syndrome. Biol Med. 2009; 1(3):44-9.

Polak G, Kozioł-Montewka M, Gogacz M, et al. Total antioxidant status in peritoneal fluid in infertile women. Eur J Obstet Gynecol Reprod Biol. 2001; 94:261-63. PMid: 11165736 DOI:

Moti M, Amini L, MirhoseiniArdakani SS, et al. Oxidative stress and antioxidant defense system in Iranian women with polycystic ovary syndrome. Iran J Reprod Med. 2015; 13:373-78.

Morelli NR, Scavuzzi BM, Miglioranza LHDS, et al. Metabolic syndrome components are associated with oxidative stress in overweight and obese patients. Arch Endocrinol Metab. 2018; 62:309-18. PMid:29791650 DOI: